{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Fièvre jaune : Questions médicales les plus fréquentes",
"headline": "Fièvre jaune : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Fièvre jaune : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-06",
"dateModified": "2025-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Fièvre jaune"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Fièvres hémorragiques virales",
"url": "https://questionsmedicales.fr/mesh/D006482",
"about": {
"@type": "MedicalCondition",
"name": "Fièvres hémorragiques virales",
"code": {
"@type": "MedicalCode",
"code": "D006482",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.782.417"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Fièvre jaune",
"alternateName": "Yellow Fever",
"code": {
"@type": "MedicalCode",
"code": "D015004",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Pedro Augusto Alves",
"url": "https://questionsmedicales.fr/author/Pedro%20Augusto%20Alves",
"affiliation": {
"@type": "Organization",
"name": "Instituto René Rachou/Fundação Oswaldo Cruz, 30190-002 Belo Horizonte, Minas Gerais, Brazil."
}
},
{
"@type": "Person",
"name": "Erna Geessien Kroon",
"url": "https://questionsmedicales.fr/author/Erna%20Geessien%20Kroon",
"affiliation": {
"@type": "Organization",
"name": "Departament of Microbiology, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil."
}
},
{
"@type": "Person",
"name": "Betânia Paiva Drumond",
"url": "https://questionsmedicales.fr/author/Bet%C3%A2nia%20Paiva%20Drumond",
"affiliation": {
"@type": "Organization",
"name": "Departament of Microbiology, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil."
}
},
{
"@type": "Person",
"name": "Anna-Bella Failloux",
"url": "https://questionsmedicales.fr/author/Anna-Bella%20Failloux",
"affiliation": {
"@type": "Organization",
"name": "Institut Pasteur, Université Paris Cité, Arboviruses and Insect Vectors, Paris, France. anna-bella.failloux@pasteur.fr."
}
},
{
"@type": "Person",
"name": "Laurence Cibrelus",
"url": "https://questionsmedicales.fr/author/Laurence%20Cibrelus",
"affiliation": {
"@type": "Organization",
"name": "World Health Organisation, Geneva, Switzerland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Introduction of a hexavalent vaccine containing acellular pertussis into the national immunization program for infants in Peru: a cost-consequence analysis of vaccination coverage.",
"datePublished": "2024-10-10",
"url": "https://questionsmedicales.fr/article/39390544",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-024-11684-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "From both sides of the needle: Understanding effective interventions for facilitating non-national immunization program vaccine decision making in China.",
"datePublished": "2024-08-22",
"url": "https://questionsmedicales.fr/article/39171499",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/21645515.2024.2389578"
}
},
{
"@type": "ScholarlyArticle",
"name": "Public health impact and cost-effectiveness of rotavirus vaccination in China: Comparison between private market provision and national immunization programs.",
"datePublished": "2022-07-11",
"url": "https://questionsmedicales.fr/article/35816415",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/21645515.2022.2090162"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Frequency of Rotavirus Gastroenteritis in Children from West of Iran and Genotyping of Rotavirus Isolates: A Suggestion for Further Changes in Childhood Immunization Program.",
"datePublished": "2024-07-31",
"url": "https://questionsmedicales.fr/article/39311104",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.34172/jrhs.2024.156"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-effectiveness analysis of introducing rotavirus vaccine into immunization program in Zhejiang province, China: A decision tree-Markov model study.",
"datePublished": "2023-07-16",
"url": "https://questionsmedicales.fr/article/37455405",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/21645515.2023.2217075"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies virales",
"item": "https://questionsmedicales.fr/mesh/D014777"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections à virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012327"
},
{
"@type": "ListItem",
"position": 5,
"name": "Fièvres hémorragiques virales",
"item": "https://questionsmedicales.fr/mesh/D006482"
},
{
"@type": "ListItem",
"position": 6,
"name": "Fièvre jaune",
"item": "https://questionsmedicales.fr/mesh/D015004"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Fièvre jaune - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Fièvre jaune",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Fièvre jaune",
"description": "Comment diagnostique-t-on la fièvre jaune ?\nQuels tests sont utilisés pour confirmer la fièvre jaune ?\nQuels symptômes indiquent une fièvre jaune ?\nLa fièvre jaune peut-elle être confondue avec d'autres maladies ?\nQuel rôle joue l'historique de voyage dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Immunization+Programs&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Fièvre jaune",
"description": "Quels sont les premiers symptômes de la fièvre jaune ?\nLa jaunisse est-elle un symptôme de la fièvre jaune ?\nQuels symptômes indiquent une forme sévère de la maladie ?\nLes symptômes de la fièvre jaune évoluent-ils rapidement ?\nPeut-on avoir des symptômes sans être infecté ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Immunization+Programs&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Fièvre jaune",
"description": "Comment se protéger contre la fièvre jaune ?\nLa vaccination est-elle efficace contre la fièvre jaune ?\nÀ quel âge peut-on se faire vacciner contre la fièvre jaune ?\nFaut-il un certificat de vaccination pour voyager ?\nLes moustiquaires sont-elles utiles pour la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Immunization+Programs&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Fièvre jaune",
"description": "Quel est le traitement principal pour la fièvre jaune ?\nLes antibiotiques sont-ils efficaces contre la fièvre jaune ?\nComment gérer la déshydratation due à la fièvre jaune ?\nDes soins intensifs sont-ils nécessaires pour les cas graves ?\nPeut-on prévenir la fièvre jaune par des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Immunization+Programs&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Fièvre jaune",
"description": "Quelles sont les complications possibles de la fièvre jaune ?\nLa fièvre jaune peut-elle entraîner la mort ?\nQuels organes peuvent être affectés par la fièvre jaune ?\nLes complications surviennent-elles rapidement ?\nPeut-on récupérer complètement après des complications ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Immunization+Programs&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Fièvre jaune",
"description": "Qui est le plus à risque de contracter la fièvre jaune ?\nLes voyageurs doivent-ils se faire vacciner avant de partir ?\nLes personnes âgées sont-elles plus vulnérables ?\nLes personnes immunodéprimées sont-elles à risque ?\nLes conditions de vie influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Immunization+Programs&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la fièvre jaune ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur les symptômes cliniques et des tests sanguins pour détecter le virus."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer la fièvre jaune ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques et la PCR sont utilisés pour confirmer la présence du virus."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une fièvre jaune ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, frissons, douleurs musculaires, et jaunisse sont des symptômes clés."
}
},
{
"@type": "Question",
"name": "La fièvre jaune peut-elle être confondue avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec la dengue ou l'hépatite virale."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique de voyage dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un historique de voyage dans des zones endémiques est crucial pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les premiers symptômes de la fièvre jaune ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les premiers symptômes incluent fièvre, frissons, et douleurs musculaires."
}
},
{
"@type": "Question",
"name": "La jaunisse est-elle un symptôme de la fièvre jaune ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la jaunisse apparaît souvent dans les cas avancés de fièvre jaune."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une forme sévère de la maladie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements, des douleurs abdominales et une défaillance organique signalent une forme sévère."
}
},
{
"@type": "Question",
"name": "Les symptômes de la fièvre jaune évoluent-ils rapidement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent évoluer rapidement, nécessitant une attention médicale urgente."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans être infecté ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes similaires peuvent apparaître sans infection, nécessitant un diagnostic précis."
}
},
{
"@type": "Question",
"name": "Comment se protéger contre la fièvre jaune ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisez des répulsifs, portez des vêtements longs et évitez les zones à moustiques."
}
},
{
"@type": "Question",
"name": "La vaccination est-elle efficace contre la fièvre jaune ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaccination est très efficace et recommandée pour les voyageurs dans les zones à risque."
}
},
{
"@type": "Question",
"name": "À quel âge peut-on se faire vacciner contre la fièvre jaune ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination est recommandée à partir de 9 mois."
}
},
{
"@type": "Question",
"name": "Faut-il un certificat de vaccination pour voyager ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un certificat de vaccination peut être exigé pour entrer dans certains pays."
}
},
{
"@type": "Question",
"name": "Les moustiquaires sont-elles utiles pour la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les moustiquaires traitées sont efficaces pour réduire les piqûres de moustiques."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour la fièvre jaune ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique; le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre la fièvre jaune ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces car la fièvre jaune est causée par un virus."
}
},
{
"@type": "Question",
"name": "Comment gérer la déshydratation due à la fièvre jaune ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation par voie intraveineuse est essentielle pour gérer la déshydratation."
}
},
{
"@type": "Question",
"name": "Des soins intensifs sont-ils nécessaires pour les cas graves ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les cas graves peuvent nécessiter des soins intensifs pour surveiller les organes."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la fièvre jaune par des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention repose principalement sur la vaccination, pas sur des traitements."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la fièvre jaune ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance hépatique, les saignements et le choc."
}
},
{
"@type": "Question",
"name": "La fièvre jaune peut-elle entraîner la mort ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fièvre jaune peut être mortelle, surtout sans traitement approprié."
}
},
{
"@type": "Question",
"name": "Quels organes peuvent être affectés par la fièvre jaune ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le foie, les reins et le cœur peuvent être gravement affectés par la maladie."
}
},
{
"@type": "Question",
"name": "Les complications surviennent-elles rapidement ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent survenir dans les 7 à 10 jours suivant l'infection."
}
},
{
"@type": "Question",
"name": "Peut-on récupérer complètement après des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines personnes peuvent récupérer complètement, mais d'autres peuvent avoir des séquelles."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque de contracter la fièvre jaune ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes vivant ou voyageant dans des zones endémiques sont les plus à risque."
}
},
{
"@type": "Question",
"name": "Les voyageurs doivent-ils se faire vacciner avant de partir ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaccination est fortement recommandée pour les voyageurs vers des zones à risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir un risque accru de complications graves."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées courent un risque plus élevé de maladie sévère."
}
},
{
"@type": "Question",
"name": "Les conditions de vie influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, vivre dans des zones avec des moustiques augmente le risque de transmission."
}
}
]
}
]
}
Infant vaccination coverage rates in Peru have declined in recent years, exacerbated by the COVID-19 pandemic. Introduction of the fully-liquid diphtheria, tetanus, and acellular pertussis (DTaP)-inac...
The analysis was performed over a 5-year period on a cohort of children born in Peru in 2020 (N = 494,595). Four scenarios were considered: the pentavalent plus IPV/OPV scheme (S1); replacing the pent...
The overall cost from a public health payer perspective associated with the pentavalent plus IPV/OPV vaccine scheme (S1) was estimated at $56,719,350, increasing to $61,324,263 (+ 8.1%), $59,121,545 (...
Implementation of the hexavalent vaccine in Peru's National Immunization Program has a positive public health cost consequence....
Vaccination decisions are influenced by various psychological and practical factors. In China, non-National Immunization Program (non-NIP) vaccines, which are voluntary and self-paid, add uncertainty ...
In China, progress to include the RV vaccine in the national immunization program (NIP) is slow. The only two vaccines, the Lanzhou lamb rotavirus vaccine (LLR) and Rotateq, are provided through the p...
Rotavirus is the most common cause of gastroenteritis among children. Currently, four oral live-attenuated vaccines are available to prevent rotavirus infection. The World Health Organization (WHO) ha...
In this case series study, 284 cases under six years of age who presented with acute gastroenteritis from March 2021 to 2022 to a referral hospital in the west of Iran were evaluated. Data on baseline...
Results showed that the prevalence of rotavirus infection was 36.6%. The highest frequency was observed among children aged 6-12 months and during the autumn. According to the PCR results, G1P[8], G9P...
The study highlights the considerable prevalence of rotavirus infection among cases of acute gastroenteritis in children under six years of age who were referred to a referral hospital in the west of ...
Two RV vaccines have been licensed in Zhejiang province, China, including the pentavalent RotaTeq (RV5) and the monovalent RV vaccine (RV1). This study aimed to evaluate the cost-effectiveness of RV1 ...
The application of the National Immunization Information System at primary health facilities is crucial in improving the quality of medical examinations as well as collecting and reporting immunizatio...
Despite widespread use of pneumococcal vaccines throughout Europe, the burden of pneumococcal disease (PD) in adults is considerable. To mitigate this burden, National Immunization Technical Advisory ...
Thailand introduced a two-dose regimen of bivalent HPV vaccines for Grade 5 schoolgirls, approximately 11 years old, initially piloted in Ayutthaya province in 2014, and nationwide under the National ...
Immunization is a crucial preventive measure to safeguard children under five years old against a range of diseases. In China, the coverage rate of non-National Immunization Program (non-NIP) vaccines...
A cross-sectional survey was conducted using a multi-stage sampling method in 2019 from August to October. 627 public health workers were recruited from 148 community healthcare centers in ten provinc...
Of the 610 public health workers with complete survey data, 53.8%, 57.4%, 84.1%, and 54.1% often recommended Hib vaccine, pneumococcal pneumonia vaccine (PCV), varicella vaccine, and rotavirus vaccine...
The findings highlighted public health workers' recommendation behaviors of non-NIP vaccines in China and revealed strong association between vaccine recommendation and financial incentives. This high...
This study aimed to understand the willingness of and affecting factors of non-national immunization program (non-NIP) vaccines among children's parents during the COVID-19 era in Shanghai, China. A c...